China Biotech Services Holdings Limited released its Interim Report 2026 on 30 September 2026. The full bilingual document is now accessible on both the company’s website (www.cbshhk.com) and Hong Kong Exchanges and Clearing’s website (www.hkexnews.hk).

Registered shareholders who have not yet provided an email address—or whose existing email on file is invalid—can switch from printed notices to electronic notifications. To do so, shareholders should complete the enclosed reply form and return it by email to 8037-corpcomm@unionregistrars.com.hk or deliver it to Union Registrars Limited, the Hong Kong Branch Share Registrar, at Suites 3301-04, 33/F, Two Chinachem Exchange Square, 338 King’s Road, North Point, Hong Kong. Domestic mail within Hong Kong does not require postage when using the provided mailing label; overseas shareholders must affix appropriate postage.

Shareholders may request printed copies of any corporate communication at any time, free of charge, by written or email request to the registrar. Those encountering difficulties accessing documents online can similarly obtain hard-copy versions upon request.

For further queries, shareholders can contact Union Registrars Limited on +852 2849 3399 during business hours (09:00–17:00, Monday to Friday, excluding Hong Kong public holidays).